Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17716862
DOI
10.1016/j.cellsig.2007.07.018
PII: S0898-6568(07)00235-5
Knihovny.cz E-resources
- MeSH
- Actins metabolism MeSH
- Cell Membrane drug effects metabolism MeSH
- Cholesterol metabolism MeSH
- Cytoskeleton drug effects metabolism MeSH
- Detergents MeSH
- Phosphotyrosine metabolism MeSH
- Hepatocytes drug effects metabolism MeSH
- Interleukin-6 pharmacology MeSH
- Caveolins metabolism MeSH
- Rats MeSH
- Humans MeSH
- Multiprotein Complexes chemistry metabolism MeSH
- Cell Line, Tumor MeSH
- Solubility drug effects MeSH
- Cell Separation MeSH
- Signal Transduction drug effects MeSH
- Subcellular Fractions metabolism MeSH
- STAT3 Transcription Factor metabolism MeSH
- Tubulin metabolism MeSH
- Vanadates pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Actins MeSH
- Cholesterol MeSH
- Detergents MeSH
- Phosphotyrosine MeSH
- Interleukin-6 MeSH
- Caveolins MeSH
- Multiprotein Complexes MeSH
- pervanadate MeSH Browser
- STAT3 Transcription Factor MeSH
- Tubulin MeSH
- Vanadates MeSH
Interleukin 6 (IL-6) is a pleiotropic cytokine that mediates a variety of functions, including induction of the acute-phase response in hepatocytes. IL-6 initiates its action by binding to its cell surface receptor, followed by activation of Janus kinases and tyrosine phosphorylation of the signal transducer and transcription factor (STAT) 3. Although it has been suggested that cholesterol- and sphingolipid-enriched membrane domains, called lipid rafts, and caveolin are involved in this process, their roles in the earliest stages of IL-6-mediated signaling are far from being understood. Here we show that pretreatment of HepG2 hepatoma cells with methyl-beta-cyclodextrin (MbetaCD), which removes cholesterol and destroys lipid rafts, inhibited tyrosine phosphorylation of STAT3 in IL-6-activated, but not PV-activated cells. Furthermore, when the cells were lysed under conditions preserving lipid rafts, no IL-6- or PV-induced phosphorylation of STAT3 was observed. Although most of the STAT3 was found in large MbetaCD-resistant assemblies in both non-activated and IL-6-activated cells, its association with lipid rafts was weak or undetectable. The extent of IL-6-induced tyrosine phosphorylation of STAT3 was comparable in cells expressing low or high levels of caveolin. Similar STAT3 transducer complexes were observed in freshly isolated rat hepatocytes. The combined data suggest that STAT3 tyrosine phosphorylation occurs in preformed transducer complexes that can be activated in the absence of intact lipid rafts or caveolin.
References provided by Crossref.org